110 related articles for article (PubMed ID: 21227512)
21. Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis.
Bharti AC; Panigrahi A; Sharma PK; Gupta N; Kumar R; Shukla S; Bhowmik DM; Agarwal SK; Guleria S; Mehra NK
Exp Clin Transplant; 2010 Jun; 8(2):161-71. PubMed ID: 20565374
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-2 and interferon-gamma mRNA expression in canine anal furunculosis lesions and the effect of ciclosporin therapy.
Tivers MS; Catchpole B; Gregory SP; House AK
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):31-6. PubMed ID: 18541310
[TBL] [Abstract][Full Text] [Related]
24. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
[TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
Flores MG; Zhang S; Ha A; Holm B; Reitz BA; Morris RE; Borie DC
J Immunol Methods; 2004 Jun; 289(1-2):123-35. PubMed ID: 15251418
[TBL] [Abstract][Full Text] [Related]
26. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
[TBL] [Abstract][Full Text] [Related]
27. Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patients.
Böhler T; Canivet C; Nguyen PN; Galvani S; Thomsen M; Durand D; Salvayre R; Negre-Salvayre A; Rostaing L; Kamar N
Cytokine; 2009 Mar; 45(3):169-73. PubMed ID: 19147373
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
29. Intracellular cytokine profiles and T cell activation in pulmonary sarcoidosis.
Hill TA; Lightman S; Pantelidis P; Abdallah A; Spagnolo P; du Bois RM
Cytokine; 2008 Jun; 42(3):289-92. PubMed ID: 18485728
[TBL] [Abstract][Full Text] [Related]
30. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
32. Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs.
Archer TM; Mulligan C; Narayanan L; Riggs C; Fellman C; Thomason JM; Wills RW; Boothe DM; Cruz-Espindola C; Harmon R; Mackin AJ
J Vet Intern Med; 2020 May; 34(3):1206-1213. PubMed ID: 32052895
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory in vitro effects of oclacitinib on canine T-cell proliferation and cytokine production.
Banovic F; Tarigo J; Gordon H; Barber JP; Gogal RM
Vet Dermatol; 2019 Feb; 30(1):17-e6. PubMed ID: 30417482
[TBL] [Abstract][Full Text] [Related]
34. Alterations in activated T-cell cytokine expression in healthy dogs over the initial 7 days of twice daily dosing with oral cyclosporine.
Riggs C; Narayanan L; Mulligan C; Wills R; Mackin A; Fellman C; Thomason J; Archer T
J Vet Pharmacol Ther; 2019 Jul; 42(4):385-391. PubMed ID: 30933369
[TBL] [Abstract][Full Text] [Related]
35. Cytokines and cell surface receptors as target end points of immunosuppression with cyclosporine A.
Sindhi R; Allaert J; Gladding D; Koppelman B; Dunne JF
J Interferon Cytokine Res; 2001 Jul; 21(7):507-14. PubMed ID: 11506745
[TBL] [Abstract][Full Text] [Related]
36. [Effect of icariin on intermediate and advanced activation of murine T lymphocytes in vitro].
Teng F; Zeng YY; Huang XY; Yang Z; Yao ML; Song B; Li L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1059-61. PubMed ID: 18992191
[TBL] [Abstract][Full Text] [Related]
37. In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates.
Stalder M; Bîrsan T; Hubble RW; Paniagua RT; Morris RE
J Heart Lung Transplant; 2003 Dec; 22(12):1343-52. PubMed ID: 14672749
[TBL] [Abstract][Full Text] [Related]
38. Behavioral conditioning of immunosuppression is possible in humans.
Goebel MU; Trebst AE; Steiner J; Xie YF; Exton MS; Frede S; Canbay AE; Michel MC; Heemann U; Schedlowski M
FASEB J; 2002 Dec; 16(14):1869-73. PubMed ID: 12468450
[TBL] [Abstract][Full Text] [Related]
39. Recovery of T-cell function in healthy dogs following cessation of oral cyclosporine administration.
Narayanan L; Mulligan C; Durso L; Thames B; Thomason J; Fellman C; Mackin A; Wills R; Archer T
Vet Med Sci; 2020 Aug; 6(3):277-282. PubMed ID: 31914237
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs.
Beagles KE; Peterson L; Zhang X; Morris J; Kiem HP
Hum Gene Ther; 2005 Jun; 16(6):725-33. PubMed ID: 15960603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
